Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs11649162 | chr16:89807131 | C/A | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs11649229 | chr16:90049589 | C/T | 1.11E-8 | 172 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs11649501 | chr16:89850957 | A/T | 0.000168 | 177 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs11649510 | chr16:89851004 | A/G | 0.000168 | 177 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs11656351 | chr17:9489575 | A/G | 9.69E-6 | 178 | 25.17 | 26.92 | 24.53 | KM Plot |
PCPG | rs116568909 | chr8:11513096 | A/G | 0.000428 | 178 | 25.17 | 25.87 | 19.93 | KM Plot |
PCPG | rs11658240 | chr17:80484139 | A/G | 7.94E-7 | 176 | 25.77 | 22.33 | 8.75 | KM Plot |
PCPG | rs11677736 | chr2:239087198 | A/T | 6.86E-5 | 178 | 29.5 | 18.2 | 13.27 | KM Plot |
PCPG | rs11679528 | chr2:239073506 | C/A | 4.34E-6 | 172 | 29.43 | 18.2 | 13.17 | KM Plot |
PCPG | rs11683147 | chr2:2743962 | T/C | 3.49E-5 | 173 | 25.6 | 23.43 | 21.68 | KM Plot |
PCPG | rs11684892 | chr2:121540592 | C/G | 0.000252 | 175 | 25.35 | 24.23 | 59.77 | KM Plot |
PCPG | rs116849218 | chr12:56683975 | C/T | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs11685068 | chr2:121541012 | C/T | 0.000252 | 175 | 25.35 | 24.23 | 59.77 | KM Plot |
PCPG | rs11685179 | chr2:121541075 | G/A | 0.000214 | 177 | 25.53 | 24.37 | 59.77 | KM Plot |
PCPG | rs11686291 | chr2:2745603 | G/A | 3.49E-5 | 173 | 25.6 | 23.43 | 21.68 | KM Plot |